150 related articles for article (PubMed ID: 6587136)
1. [CA 19-9, a new tumor marker].
Akai S
Rinsho Byori; 1983 Dec; 31(12):1300-2. PubMed ID: 6587136
[No Abstract] [Full Text] [Related]
2. [Tumor markers for pancreatic and biliary tract cancer].
Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of CA 19-9 radioimmunoassay].
Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
[TBL] [Abstract][Full Text] [Related]
4. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
DelVillano BC; Zurawski VR
Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
[No Abstract] [Full Text] [Related]
5. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
Shimano T; Morimoto H; Saito M; Mori T
Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
[No Abstract] [Full Text] [Related]
6. CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases.
Paganuzzi M; Onetto M; Marroni P; Barone D; Conio M; Aste H; Pugliese V
Cancer; 1988 May; 61(10):2100-8. PubMed ID: 2834038
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice].
Skvortsov SV; Lytsar' BN; Kalinin AV; Dolinskiĭ AG
Klin Med (Mosk); 1992; 70(5-6):21-3. PubMed ID: 1279265
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of CA 50 assay as a tumor marker].
Hara K; Mitsuhashi F; Ohkura H
Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
[No Abstract] [Full Text] [Related]
9. [Basic and clinical studies on the measurement of serum CA 19-9].
Imazeki K; Kitakata Y; Uno K; Koga T; Kawana M; Arimizu N; Saisho H; Uematsu S
Kaku Igaku; 1986 Jun; 23(6):855-61. PubMed ID: 3463815
[No Abstract] [Full Text] [Related]
10. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
Klapdor R; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
[No Abstract] [Full Text] [Related]
11. [DU-PAN-2 antigen in the serum of patients with tumors of the pancreas or biliary tract].
Ohshio G; Hamashima Y; Manabe T; Miyashita T; Suzuki T; Tobe T
Nihon Geka Gakkai Zasshi; 1987 Mar; 88(3):359. PubMed ID: 3600587
[No Abstract] [Full Text] [Related]
12. Carbohydrate antigen (CA 19-9)--a valuable tumor marker of pancreatic cancer.
Lin JT; Wang TH; Sung JL; Chen DS
Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):828-35. PubMed ID: 3864924
[No Abstract] [Full Text] [Related]
13. [Clinical significance of CA 195 assay as a tumor marker].
Ohkura H; Sakawaki T
Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
[No Abstract] [Full Text] [Related]
14. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
Pecchio F; Ricci E; Rapellino M; Oliaro A; Adamo MR; Marzola G; Piantino P
Minerva Med; 1987 Feb; 78(3):141-4. PubMed ID: 3469541
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
Sawabu N; Satomura Y
Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
[No Abstract] [Full Text] [Related]
16. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of YH-206 assay analysis as a tumor marker].
Yachi A; Hinoda Y; Imai K; Endo T
Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
[No Abstract] [Full Text] [Related]
18. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
Yamaguchi K; Nagano M; Torada N; Hamasaki N; Kawakita M; Tanaka M
Rinsho Byori; 2004 Apr; 52(4):336-9. PubMed ID: 15164602
[TBL] [Abstract][Full Text] [Related]
19. [Immunological markers in the detection of neoplasms of the liver, biliary tract and pancreas].
Matsuno S; Kobari M; Kodera T; Sato T
Nihon Rinsho; 1982; 40(1):51-7. PubMed ID: 6177882
[No Abstract] [Full Text] [Related]
20. [Diagnosis of recurrence and evaluation of the course of pancreatic cancer. Combined use of sonography and the new tumor marker CA 19-9].
Guthoff A; Klapdor U; Klapdor R; Eichfuss HP; Dallek M; Greten H
Dtsch Med Wochenschr; 1984 Sep; 109(37):1410-2. PubMed ID: 6383759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
